Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RHIVIERA-02: bNAbs + ART vs Placebo + ART in Primary HIV-1 Infection
NCT05300035Phase 2Recruiting
- Sponsor
- ANRS
- Start
- Apr 2024
- Primary completion
- Dec 2026
- Modality
- Anti-infectious Disease mAbs
- Countries
- 1
01
Overview
A Phase 2 trial of Teropavimab, zinlirvimab in human immunodeficiency virus infection (HIV), sponsored by ANRS. Started Apr 2024; status: recruiting.
02
Drugs
Teropavimabzinlirvimab
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT05300035.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05300035.